首页 > 市场调查报告书 > 医疗设备

眼科设备

眼内植入市场规模、份额和成长分析（按产品、应用、最终用户和地区划分）—产业预测（2025-2032 年）

市场调查报告书

商品编码

1865334

眼内植入市场规模、份额和成长分析（按产品、应用、最终用户和地区划分）—产业预测（2025-2032 年）

Ocular Implants Market Size, Share, and Growth Analysis, By Product (Intraocular Lenses (IOLs), Corneal Implants), By Application (Cataract Surgery, Refractive Errors), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月05日 | 出版商:

SkyQuest | 英文 170 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2023 年，全球眼内植入市场规模将达到 153 亿美元，到 2024 年将达到 161.7 亿美元，到 2032 年将达到 252 亿美元，预测期（2025-2032 年）的复合年增长率为 5.7%。

全球人工眼内植入市场正经历显着成长，这主要得益于眼科疾病发病率的上升、人口老化的快速发展以及眼科研发领域的大量投资。白内障、青光眼、老龄化黄斑部病变和糖尿病视网膜病变等眼科疾病的增加，主要归因于不良的生活习惯和长时间接触电子萤幕。此外，老年人口尤其容易出现视力问题，从而推动了对人工眼内植入的需求。大众对可预防性失明及其治疗方案的认识不断提高，预计也将促进市场普及。此外，眼科设施和手术技术的进步也为市场销售提供了支持，但挑战仍然存在，包括高昂的费用、熟练专业人员短缺、报销管道有限以及术后併发症的风险。

全球眼内植入市场驱动因素

全球眼内植入市场的主要驱动因素之一是白内障、青光眼和老龄化黄斑部病变等视力相关疾病的日益普遍。人口老化和生活方式因素导致这些眼科疾病率上升，进而推动了对创新手术治疗方案（包括先进的眼内植入）的需求。此外，植入设计和微创手术技术的进步正在改善患者的治疗效果和安全性，进一步促进了这些设备的应用。随着医疗机构致力于改善视力保健，不断变化的患者需求和医疗创新预计将显着推动眼内植入市场的成长。

限制全球眼内植入市场的因素

全球眼内植入市场的主要限制因素之一是先进的眼内植入手术和器械的高昂费用。这种经济负担可能会阻碍患者接受必要的治疗，尤其是在医疗预算有限、保险覆盖不足的新兴经济体。此外，植入手术的复杂性会导致恢復时间延长和併发症风险增加，进一步降低潜在患者的治疗意愿。监管壁垒和冗长的新产品核准流程也会阻碍创新并增加成本，可能限制市场成长，并影响有需要的患者获得尖端眼科解决方案的机会。

全球眼内植入市场趋势

全球眼内植入市场正呈现出智慧技术和药物释放型技术融合的显着趋势。各公司正加大研发投入，致力于开发先进的眼内植入，以实现对青光眼、老龄化黄斑部病变等慢性眼科疾病患者的持续药物输送和即时监测。奈米技术、无线通讯和微流体系统等创新解决方案的引入，凸显了眼内植入领域的发展趋势。这项变革不仅有望提升治疗效果，也有助于提高患者依从性，最终推动市场成长，并重塑眼科护理管理的未来。

Alcon Inc.
Johnson & Johnson Vision（Johnson & Johnson）
Bausch+Lomb Inc.
Carl Zeiss AG
STAAR Surgical Company
Hoya Corporation（Surgical Optics division）
Glaukos Corporation
Novartis AG（Ophthalmic implants）
MORCHER GmbH
OSD Medical GmbH
Pfizer Inc.（Ophthalmic device/implants segment）
Ophtec BV
Rayner Intraocular Lenses Limited
SIFI SpA
Lenstec Inc.
HumanOptics AG
Alcon Laboratories（a Novartis company）（duplicate replaced）
Second Sight Medical Products Inc.
OptiMedica Corporation（implants segment）
Envision Surgical Technologies Inc.

结论与建议

简介目录

Product Code: SQMIG35B2264

Global Ocular Implants Market size was valued at USD 15.3 billion in 2023 and is poised to grow from USD 16.17 billion in 2024 to USD 25.2 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global ocular implants market is experiencing significant growth driven by the increasing prevalence of ocular diseases, a rapidly expanding elderly population, and substantial investments in ophthalmic research and development. The rise in eye disorders, particularly cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy, is largely attributed to poor lifestyle choices and heightened digital screen exposure. Furthermore, the aging demographic is particularly susceptible to vision-related issues, reinforcing the demand for ocular implants. Enhanced public awareness regarding preventable blindness and available treatment options is also expected to drive market adoption. Additionally, advancements in ophthalmology facilities and surgical capabilities are supporting market sales, despite challenges such as high costs, a shortage of skilled professionals, limited reimbursement options, and potential post-surgery complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ocular Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ocular Implants Market Segments Analysis

Global Ocular Implants Market is segmented by Product, Application, End-User and region. Based on Product, the market is segmented into Intraocular Lenses (IOLs), Corneal Implants, Glaucoma Implants (e.g., shunts, valves), Retinal Implants, Orbital Implants and Other Ocular Implants. Based on Application, the market is segmented into Cataract Surgery, Refractive Errors, Glaucoma Treatment, Retinal Disorders (e.g., AMD, RP), Corneal Diseases and Orbital Trauma / Reconstruction. Based on End-User, the market is segmented into Hospitals & Clinics, Ophthalmic Surgery Centres and Ambulatory Surgical Centres (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ocular Implants Market

One of the primary market drivers for the global ocular implants market is the rising prevalence of vision-related disorders, such as cataracts, glaucoma, and age-related macular degeneration. This increase in ocular conditions, driven by an aging population and lifestyle factors, is propelling the demand for innovative surgical solutions, including advanced ocular implants. Additionally, technological advancements in implant design and minimally invasive surgical techniques are enhancing patient outcomes and safety, further boosting the adoption of these devices. As healthcare providers focus on improving vision care, the ocular implants market is poised for significant growth driven by these evolving patient needs and medical innovations.

Restraints in the Global Ocular Implants Market

One significant market restraint for the global ocular implants market is the high cost associated with advanced ocular implant procedures and devices. The financial burden can deter patients from seeking necessary treatments, particularly in emerging economies where healthcare budgets are limited and insurance coverage may be inadequate. Additionally, the complex surgical nature of implant procedures can lead to prolonged recovery times and potential complications, further discouraging potential patients. Regulatory hurdles and lengthy approval processes for new products can also stifle innovation and increase costs, limiting market growth and accessibility to state-of-the-art ocular solutions for those in need.

Market Trends of the Global Ocular Implants Market

The Global Ocular Implants market is witnessing a significant trend towards the integration of smart and drug-eluting technologies. Companies are increasingly focusing on research and development to create advanced ocular implants that facilitate sustained drug delivery and real-time monitoring, catering particularly to patients with chronic eye conditions such as glaucoma and macular degeneration. The adoption of innovative solutions, including nanotechnology, wireless communication, and microfluidic systems, underscores the evolving landscape of ocular implants. This shift not only enhances treatment efficacy but also improves patient compliance, ultimately driving growth and reshaping the future of ocular health management.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape
Customer & Buying Criteria Analysis

Global Ocular Implants Market Size by Product & CAGR (2025-2032)

Market Overview
Intraocular Lenses (IOLs)
Corneal Implants
Glaucoma Implants (e.g., shunts, valves)
Retinal Implants
Orbital Implants
Other Ocular Implants

Global Ocular Implants Market Size by Application & CAGR (2025-2032)

Market Overview
Cataract Surgery
Refractive Errors
Glaucoma Treatment
Retinal Disorders (e.g., AMD, RP)
Corneal Diseases
Orbital Trauma / Reconstruction

Global Ocular Implants Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals & Clinics
Ophthalmic Surgery Centres
Ambulatory Surgical Centres (ASCs)

Global Ocular Implants Market Size & CAGR (2025-2032)

North America (Product, Application, End-User)
- US
- Canada
Europe (Product, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Alcon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision (Johnson & Johnson)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch + Lomb Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STAAR Surgical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoya Corporation (Surgical Optics division)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glaukos Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Ophthalmic implants)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MORCHER GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OSD Medical GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (Ophthalmic device/implants segment)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ophtec BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rayner Intraocular Lenses Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIFI S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lenstec Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HumanOptics AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Laboratories (a Novartis company) (duplicate replaced)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Second Sight Medical Products Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptiMedica Corporation (implants segment)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Envision Surgical Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments